Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins-Reference-Cited by-同舟云学术

Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins

Published:2020-07-24 Issue:7 Volume:15 Page:e0235979
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tanaka Naoki,Okuda Michiaki^ORCID,Nishigaki Tatsutoshi,Tsuchiya Nobuhiko,Kobayashi Yukako,Uemura Takuya,Kumo Sayaka,Sugimoto Hachiro,Miyata Seiji,Waku Tomonori^ORCID

Funder

Japan Society for the Promotion of Science

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference62 articles.

1. Preventing Alzheimer’s disease;DJ Selkoe;Science,2012

2. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics;E Karran;Nat. Rev. Drug Discov,2011

3. Tau protein, the paired helical filament and Alzheimer's disease;M Goedert;J. Alzheimers. Dis,2006

4. Protein folding and misfolding;CM Dobson;Nature,2003

5. Structure, formation and propagation of amyloid fibrils;Y Goto;Curr. Pharm. Des,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the potential of highly porous zopiclone-loaded 3D electrospun nanofibers for brain targeting via the intranasal route;International Journal of Pharmaceutics;2024-07

2. A systematic study of nano-based fibrous systems: Diagnostic and therapeutic approaches for dementia control;Ageing Research Reviews;2023-03

3. The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review;Journal of Microencapsulation;2022-02-17

4. Targeting the brain lesions using peptides: A review focused on the possibility of targeted drug delivery to multiple sclerosis lesions;Pharmacological Research;2021-05